Invention Grant
US11951162B2
有权
- Patent Title:
-
Application No.: US17047563Application Date: 2019-04-18
-
Publication No.: US11951162B2Publication Date: 2024-04-09
- Inventor: Hun Kim , Dong Soo Ham , Jin-Hwan Shin , Kyung-jun An , Sung-hyun Kim
- Applicant: SK BIOSCIENCE CO., LTD.
- Applicant Address: KR Seongnam-si
- Assignee: SK BIOSCIENCE CO., LTD.
- Current Assignee: SK BIOSCIENCE CO., LTD.
- Current Assignee Address: KR Seongnam-si
- Agency: MH2 TECHNOLOGY LAW GROUP, LLP
- Priority: KR 20180045245 2018.04.18 KR 20180045246 2018.04.18 KR 20180045247 2018.04.18 KR 20180045248 2018.04.18
- International Application: PCT/KR2019/004717 2019.04.18
- International Announcement: WO2019/203599A 2019.10.24
- Date entered country: 2020-10-14
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61K47/61 ; C07K14/315

Abstract:
The present invention provides an immunogenic composition comprising a Streptococcus pneumoniae polysaccharide-protein conjugate, comprising a capsular polysaccharide derived from one or more selected from the group consisting of serotypes 1, 2, 3, 4, 5, 6A, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F, derived from Streptococcus pneumoniae; and one or 2 or more of carrier proteins conjugated to the respective capsular polysaccharide, and method of preparation thereof. Through one example of the present invention, an immunogenic composition for preventing or treating pneumococcal infection can be provided.
Public/Granted literature
- US20210154287A1 STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND IMMUNOGENIC CONJUGATE THEREOF Public/Granted day:2021-05-27
Information query